A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors

A study to evaluate the safety, tolerability, pk, and efficacy of XS-02 capsules in patients with advanced solid tumors.

Trial Details

NCT ID
NCT06531486
Phase
PHASE1
Sponsor
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status
RECRUITING
Cancer Type
Endometrial Cancer Uterine Cancer
Interventions
  • XS-02 capsules
Locations (sample)
  • Beijing, Beijing Municipality, China|39.9075,116.39723

Key Eligibility Criteria

  • Patients must meet all of the following criteria for admission:
  • Volunteer to participate in clinical trials and sign an informed consent form (ICF).
  • Age ≥18 years old, ≤75 years old, regardless of gender.
  • Phase Ia: patients with histologically or cytologically confirmed locally advanced or metastatic solid tumors for whom no standard therapy is avail…

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Endometrial Cancer Uterine Cancer Trials on Trialify →